Vanguard CIV H3N2/H3N8This page contains information on Vanguard CIV H3N2/H3N8 for veterinary use.
The information provided typically includes the following:
- Vanguard CIV H3N2/H3N8 Indications
- Warnings and cautions for Vanguard CIV H3N2/H3N8
- Direction and dosage information for Vanguard CIV H3N2/H3N8
Vanguard CIV H3N2/H3N8This treatment applies to the following species:
Canine Influenza Vaccine, H3N2 & H3N8, Killed Virus
For use by, or under the supervision of, a veterinarian.
This product has been shown to be effective for the vaccination of healthy dogs against canine influenza (H3N2 and H3N8) virus infection. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.
Directions For Use
Vaccination of healthy dogs is recommended. Shake well. Aseptically administer 1 mL subcutaneously. Healthy dogs 8 weeks of age and older should receive 2 doses administered 3 weeks apart. The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian is recommended.
PrecautionsStore at 2°-8°C. Prolonged exposure to higher temperatures may adversely affect potency. Do not freeze. Sterilized syringes and needles should be used to administer this vaccine. Contains gentamicin as preservative. This product has not been tested in pregnant animals. Do not mix with other products. In case of human exposure, contact a physician.
Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471.
For veterinary use only
VLN 190/PCN 15Q5.20
Zoetis Inc., Kalamazoo, MI 49007, USA
25 1-dose (1-mL) vials of vaccine
333 PORTAGE STREET, KALAMAZOO, MI, 49007
|Every effort has been made to ensure the accuracy of the Vanguard CIV H3N2/H3N8 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2018 North American Compendiums. Updated: 2018-02-26